{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T16:59:27Z","timestamp":1790096367132,"version":"4.0.1"},"reference-count":67,"publisher":"The Endocrine Society","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,11,1]]},"DOI":"10.1210\/jc.2017-01643","type":"journal-article","created":{"date-parts":[[2017,9,13]],"date-time":"2017-09-13T18:04:49Z","timestamp":1505325889000},"page":"3914-3923","source":"Crossref","is-referenced-by-count":273,"title":["Sex Steroids and Cardiovascular Outcomes in Transgender Individuals: A Systematic Review and Meta-Analysis"],"prefix":"10.1210","volume":"102","author":[{"given":"Spyridoula","family":"Maraka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naykky","family":"Singh Ospina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rene","family":"Rodriguez-Gutierrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline J","family":"Davidge-Pitts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd B","family":"Nippoldt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larry J","family":"Prokop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M Hassan","family":"Murad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2017,9,13]]},"reference":[{"issue":"6","key":"key\n\t\t\t\t20171106135757_B1","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.eurpsy.2015.04.005","article-title":"Systematic review and meta-analysis of prevalence studies in transsexualism","volume":"30","year":"2015","journal-title":"Eur Psychiatry"},{"key":"key\n\t\t\t\t20171106135757_B2","first-page":"31","article-title":"Hormone treatment of the adult transsexual patient","volume":"64","year":"2005","journal-title":"Horm Res"},{"issue":"1","key":"key\n\t\t\t\t20171106135757_B3","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0025-6196(11)60964-6","article-title":"Testosterone and cardiovascular risk in men: a systematic review and meta-analysis of randomized placebo-controlled trials","volume":"82","year":"2007","journal-title":"Mayo Clin Proc"},{"issue":"6","key":"key\n\t\t\t\t20171106135757_B4","first-page":"652","article-title":"The Coronary Drug Project Research Group","volume":"226","author":"The Coronary Drug Project: findings leading to discontinuation of the 2.5-mg day estrogen group","year":"1973","journal-title":"JAMA"},{"issue":"7","key":"key\n\t\t\t\t20171106135757_B5","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1001\/jama.280.7.605","article-title":"Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen\/progestin Replacement Study (HERS) Research Group","volume":"280","year":"1998","journal-title":"JAMA"},{"issue":"3","key":"key\n\t\t\t\t20171106135757_B6","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women\u2019s Health Initiative randomized controlled trial","volume":"288","author":"Writing Group for the Women\u2019s Health Initiative Investigators","year":"2002","journal-title":"JAMA"},{"issue":"4","key":"key\n\t\t\t\t20171106135757_B7","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1530\/eje.1.02126","article-title":"The effects of the aromatase inhibitor anastrozole on bone metabolism and cardiovascular risk indices in ovariectomized, androgen-treated female-to-male transsexuals","volume":"154","year":"2006","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"key\n\t\t\t\t20171106135757_B8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2265.2009.03632.x","article-title":"Effect of sex steroid use on cardiovascular risk in transsexual individuals: a systematic review and meta-analyses","volume":"72","year":"2010","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key\n\t\t\t\t20171106135757_B9","doi-asserted-by":"crossref","first-page":"b2700","DOI":"10.1136\/bmj.b2700","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration","volume":"339","year":"2009","journal-title":"BMJ"},{"key":"key\n\t\t\t\t20171106135757_B10","volume-title":"The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses"},{"key":"key\n\t\t\t\t20171106135757_B11","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials","volume":"343","author":"Cochrane Bias Methods Group","year":"2011","journal-title":"BMJ"},{"issue":"3","key":"key\n\t\t\t\t20171106135757_B12","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","year":"1986","journal-title":"Control Clin Trials"},{"issue":"7414","key":"key\n\t\t\t\t20171106135757_B13","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","year":"2003","journal-title":"BMJ"},{"key":"key\n\t\t\t\t20171106135757_B14","first-page":"1","article-title":"Closing the gap between methodologists and end-users: R as a computational back-end","volume":"49","year":"2012","journal-title":"J Stat Softw"},{"key":"key\n\t\t\t\t20171106135757_B15"},{"key":"key\n\t\t\t\t20171106135757_B16","first-page":"150","article-title":"Evaluation of cross-sex hormonal treatment in transsexuals: experience of an unit of gender identity disorders","volume":"7","year":"2009","journal-title":"Rev Int Androl"},{"issue":"6","key":"key\n\t\t\t\t20171106135757_B17","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1111\/j.1745-7262.2006.00204.x","article-title":"Testosterone decreases adiponectin levels in female to male transsexuals","volume":"8","year":"2006","journal-title":"Asian J Androl"},{"key":"key\n\t\t\t\t20171106135757_B18","article-title":"Alterations in lipids and adipocyte hormones in female-to-male transsexuals","volume":"2010","year":"2010","journal-title":"Int J Endocrinol"},{"issue":"4","key":"key\n\t\t\t\t20171106135757_B19","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.jpsychores.2015.02.001","article-title":"Concomitant psychiatric problems and hormonal treatment induced metabolic syndrome in gender dysphoria individuals: a 2 year follow-up study","volume":"78","year":"2015","journal-title":"J Psychosom Res"},{"issue":"7","key":"key\n\t\t\t\t20171106135757_B20","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/BF03350728","article-title":"Exogenous estrogen effect on lipid\/lipoprotein cholesterol in transsexual males","volume":"12","year":"1989","journal-title":"J Endocrinol Invest"},{"issue":"3","key":"key\n\t\t\t\t20171106135757_B21","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1097\/AOG.0000000000000692","article-title":"Effects of cross-sex hormone treatment on transgender women and men","volume":"125","year":"2015","journal-title":"Obstet Gynecol"},{"issue":"10","key":"key\n\t\t\t\t20171106135757_B22","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1055\/s-2005-865900","article-title":"Endocrine treatment of male-to-female transsexuals using gonadotropin-releasing hormone agonist","volume":"113","year":"2005","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"5","key":"key\n\t\t\t\t20171106135757_B23","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1046\/j.1365-2265.2003.01753.x","article-title":"Effects of sex steroids on components of the insulin resistance syndrome in transsexual subjects","volume":"58","year":"2003","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"5","key":"key\n\t\t\t\t20171106135757_B24","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1161\/01.ATV.20.5.1396","article-title":"Oral, but not transdermal, administration of estrogens lowers tissue-type plasminogen activator levels in humans without affecting endothelial synthesis","volume":"20","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"key\n\t\t\t\t20171106135757_B25","year":"2009"},{"issue":"2","key":"key\n\t\t\t\t20171106135757_B26","first-page":"95","article-title":"Body composition and bone mineral density in male-to-female transsexuals during cross-sex hormone therapy using gonadotrophin-releasing hormone agonist","volume":"119","year":"2011","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"9","key":"key\n\t\t\t\t20171106135757_B27","doi-asserted-by":"crossref","first-page":"3190","DOI":"10.1111\/j.1743-6109.2010.01912.x","article-title":"Effects of intramuscular testosterone undecanoate on body composition and bone mineral density in female-to-male transsexuals","volume":"7","year":"2010","journal-title":"J Sex Med"},{"issue":"3","key":"key\n\t\t\t\t20171106135757_B28","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1097\/00019501-200005000-00008","article-title":"Long-term oestrogen treatment does not alter systemic arterial compliance and haemodynamics in biological males","volume":"11","year":"2000","journal-title":"Coron Artery Dis"},{"issue":"4","key":"key\n\t\t\t\t20171106135757_B29","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/j.fertnstert.2008.12.017","article-title":"Incidence of thrombophilia and venous thrombosis in transsexuals under cross-sex hormone therapy","volume":"93","year":"2010","journal-title":"Fertil Steril"},{"issue":"8","key":"key\n\t\t\t\t20171106135757_B30","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1111\/j.1743-6109.2011.02311.x","article-title":"Cross-sex hormone therapy alters the serum lipid profile: a retrospective cohort study in 169 transsexuals","volume":"8","year":"2011","journal-title":"J Sex Med"},{"issue":"12","key":"key\n\t\t\t\t20171106135757_B31","doi-asserted-by":"crossref","first-page":"3002","DOI":"10.1111\/jsm.12698","article-title":"Effects of three different testosterone formulations in female-to-male transsexual persons","volume":"11","year":"2014","journal-title":"J Sex Med"},{"issue":"1","key":"key\n\t\t\t\t20171106135757_B32","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/BF01579291","article-title":"Spironolactone with physiological female steroids for presurgical therapy of male-to-female transsexualism","volume":"18","year":"1989","journal-title":"Arch Sex Behav"},{"issue":"5","key":"key\n\t\t\t\t20171106135757_B33","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1023\/A:1018704630036","article-title":"A follow-up study for estimating the effectiveness of a cross-gender hormone substitution therapy on transsexual patients","volume":"27","year":"1998","journal-title":"Arch Sex Behav"},{"issue":"4","key":"key\n\t\t\t\t20171106135757_B34","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.ejim.2004.04.009","article-title":"Serum lipids and estrogen receptor gene polymorphisms in male-to-female transsexuals: effects of estrogen treatment","volume":"15","year":"2004","journal-title":"Eur J Intern Med"},{"issue":"12","key":"key\n\t\t\t\t20171106135757_B35","doi-asserted-by":"crossref","first-page":"5723","DOI":"10.1210\/jc.2003-030520","article-title":"Venous thrombosis and changes of hemostatic variables during cross-sex hormone treatment in transsexual people","volume":"88","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"key\n\t\t\t\t20171106135757_B36","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1046\/j.1365-2265.1997.2601068.x","article-title":"Mortality and morbidity in transsexual subjects treated with cross-sex hormones","volume":"47","year":"1997","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"10","key":"key\n\t\t\t\t20171106135757_B37","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1111\/j.1743-6109.2012.02876.x","article-title":"Long-term evaluation of cross-sex hormone treatment in transsexual persons","volume":"9","year":"2012","journal-title":"J Sex Med"},{"issue":"4","key":"key\n\t\t\t\t20171106135757_B38","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1530\/EJE-13-0493","article-title":"Prevalence of cardiovascular disease and cancer during cross-sex hormone therapy in a large cohort of trans persons: a case-control study","volume":"169","year":"2013","journal-title":"Eur J Endocrinol"},{"issue":"8","key":"key\n\t\t\t\t20171106135757_B39","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1111\/jsm.12571","article-title":"Cross-sex hormone therapy in trans persons is safe and effective at short-time follow-up: results from the European network for the investigation of gender incongruence","volume":"11","year":"2014","journal-title":"J Sex Med"},{"issue":"1","key":"key\n\t\t\t\t20171106135757_B40","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.maturitas.2006.01.001","article-title":"The effect of oestrogen on cytokine and antioxidant levels in male to female transsexual patients","volume":"55","year":"2006","journal-title":"Maturitas"},{"issue":"4","key":"key\n\t\t\t\t20171106135757_B41","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1530\/EJE-10-1038","article-title":"A long-term follow-up study of mortality in transsexuals receiving treatment with cross-sex hormones","volume":"164","year":"2011","journal-title":"Eur J Endocrinol"},{"issue":"8","key":"key\n\t\t\t\t20171106135757_B42","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/0026-0495(94)90170-8","article-title":"Serum testosterone level is the major determinant of the male-female differences in serum levels of high-density lipoprotein (HDL) cholesterol and HDL2 cholesterol","volume":"43","year":"1994","journal-title":"Metabolism"},{"issue":"9","key":"key\n\t\t\t\t20171106135757_B43","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/0026-0495(89)90233-3","article-title":"Mortality and morbidity in transsexual patients with cross-gender hormone treatment","volume":"38","year":"1989","journal-title":"Metabolism"},{"issue":"5","key":"key\n\t\t\t\t20171106135757_B44","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1111\/j.1743-6109.2007.00556.x","article-title":"Long-acting intramuscular testosterone undecanoate for treatment of female-to-male transgender individuals","volume":"4","year":"2007","journal-title":"J Sex Med"},{"issue":"5","key":"key\n\t\t\t\t20171106135757_B45","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1530\/EJE-09-0412","article-title":"Safety aspects of 36 months of administration of long-acting intramuscular testosterone undecanoate for treatment of female-to-male transgender individuals","volume":"161","year":"2009","journal-title":"Eur J Endocrinol"},{"issue":"11","key":"key\n\t\t\t\t20171106135757_B46","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1161\/01.ATV.18.11.1716","article-title":"Visceral fat accumulation is an important determinant of PAI-1 levels in young, nonobese men and women: modulation by cross-sex hormone administration","volume":"18","year":"1998","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"key\n\t\t\t\t20171106135757_B47","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1210\/jcem.83.2.4574","article-title":"Effects of sex steroids on plasma total homocysteine levels: a study in transsexual males and females","volume":"83","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"key\n\t\t\t\t20171106135757_B48","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1677\/joe.0.1800107","article-title":"Established risk factors for coronary heart disease are unrelated to androgen-induced baldness in female-to-male transsexuals","volume":"180","year":"2004","journal-title":"J Endocrinol"},{"issue":"7","key":"key\n\t\t\t\t20171106135757_B49","doi-asserted-by":"crossref","first-page":"2647","DOI":"10.1016\/j.fertnstert.2010.03.048","article-title":"The impact of testosterone administration to female-to-male transsexuals on insulin resistance and lipid parameters compared with women with polycystic ovary syndrome","volume":"94","year":"2010","journal-title":"Fertil Steril"},{"issue":"9","key":"key\n\t\t\t\t20171106135757_B50","doi-asserted-by":"crossref","first-page":"3470","DOI":"10.1210\/jc.2007-0746","article-title":"Long-term administration of testosterone undecanoate every 3 months for testosterone supplementation in female-to-male transsexuals","volume":"92","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"21","key":"key\n\t\t\t\t20171106135757_B51","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1001\/jama.299.21.2543","article-title":"Patient-important outcomes in registered diabetes trials","volume":"299","year":"2008","journal-title":"JAMA"},{"issue":"7","key":"key\n\t\t\t\t20171106135757_B52","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.jclinepi.2010.08.005","article-title":"Individuals with diabetes preferred that future trials use patient-important outcomes and provide pragmatic inferences","volume":"64","year":"2011","journal-title":"J Clin Epidemiol"},{"key":"key\n\t\t\t\t20171106135757_B53","doi-asserted-by":"crossref","first-page":"d7995","DOI":"10.1136\/bmj.d7995","article-title":"The idolatry of the surrogate","volume":"343","year":"2011","journal-title":"BMJ"},{"issue":"3","key":"key\n\t\t\t\t20171106135757_B54","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1210\/jc.2007-1907","article-title":"A case for clarity, consistency, and helpfulness: state-of-the-art clinical practice guidelines in endocrinology using the grading of recommendations, assessment, development, and evaluation system","volume":"93","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"key\n\t\t\t\t20171106135757_B55","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.jclinepi.2014.11.025","article-title":"Librarian co-authors correlated with higher quality reported search strategies in general internal medicine systematic reviews","volume":"68","year":"2015","journal-title":"J Clin Epidemiol"},{"issue":"2","key":"key\n\t\t\t\t20171106135757_B56","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.jclinepi.2008.08.002","article-title":"Systematic reviewers commonly contact study authors but do so with limited rigor","volume":"62","year":"2009","journal-title":"J Clin Epidemiol"},{"issue":"5 Pt 2","key":"key\n\t\t\t\t20171106135757_B57","first-page":"1191","article-title":"Cardiovascular disease and multifactorial risk: challenge of the 1980s","volume":"106","year":"1983","journal-title":"Am Heart J"},{"issue":"7","key":"key\n\t\t\t\t20171106135757_B58","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1001\/jama.298.7.776","article-title":"Clinical utility of different lipid measures for prediction of coronary heart disease in men and women","volume":"298","year":"2007","journal-title":"JAMA"},{"issue":"19","key":"key\n\t\t\t\t20171106135757_B59","doi-asserted-by":"crossref","first-page":"H3","DOI":"10.1016\/0002-9149(92)91083-G","article-title":"Epidemiology of triglycerides: a view from Framingham","volume":"70","year":"1992","journal-title":"Am J Cardiol"},{"issue":"9493","key":"key\n\t\t\t\t20171106135757_B60","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/S0140-6736(05)67394-1","article-title":"Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins","volume":"366","author":"Cholesterol Treatment Trialists\u2019 (CTT) Collaborators","year":"2005","journal-title":"Lancet"},{"issue":"10","key":"key\n\t\t\t\t20171106135757_B61","doi-asserted-by":"crossref","first-page":"3543","DOI":"10.1210\/jc.2014-2262","article-title":"The benefits and harms of systemic testosterone therapy in postmenopausal women with normal adrenal function: a systematic review and meta-analysis","volume":"99","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t20171106135757_B62","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1186\/s12916-014-0211-5","article-title":"Cardiovascular risks and elevation of serum DHT vary by route of testosterone administration: a systematic review and meta-analysis","volume":"12","year":"2014","journal-title":"BMC Med"},{"issue":"20","key":"key\n\t\t\t\t20171106135757_B63","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1136\/heartjnl-2011-301587","article-title":"Endogenous oestradiol and cardiovascular disease in healthy men: a systematic review and meta-analysis of prospective studies","volume":"98","year":"2012","journal-title":"Heart"},{"issue":"3","key":"key\n\t\t\t\t20171106135757_B64","first-page":"CD002229","article-title":"Hormone therapy for preventing cardiovascular disease in post-menopausal women","volume":"3","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"11","key":"key\n\t\t\t\t20171106135757_B65","doi-asserted-by":"crossref","first-page":"4012","DOI":"10.1210\/jc.2015-2237","article-title":"Oral vs transdermal estrogen therapy and vascular events: a systematic review and meta-analysis","volume":"100","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"key\n\t\t\t\t20171106135757_B66","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1007\/s11892-015-0688-0","article-title":"Shared decision-making in diabetes care","volume":"15","year":"2015","journal-title":"Curr Diab Rep"},{"issue":"2","key":"key\n\t\t\t\t20171106135757_B67","doi-asserted-by":"crossref","first-page":"135","DOI":"10.7326\/M14-2482","article-title":"Lesbian, gay, bisexual, and transgender health disparities: executive summary of a policy position paper from the American College of Physicians","volume":"163","author":"Health and Public Policy Committee of American College of Physicians","year":"2015","journal-title":"Ann Intern Med"}],"container-title":["The Journal of Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/102\/11\/3914\/21533660\/jc.2017-01643.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,11,6]],"date-time":"2017-11-06T18:59:37Z","timestamp":1509994777000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/jcem\/article\/102\/11\/3914\/4157557"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,13]]},"references-count":67,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2017,9,13]]},"published-print":{"date-parts":[[2017,11,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2017-01643","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,11,1]]},"published":{"date-parts":[[2017,9,13]]}}}